![Jens Kjeldsen-Kragh](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jens Kjeldsen-Kragh active positions
Companies | Position | Start | End |
---|---|---|---|
Prophylix AS
![]() Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Chief Tech/Sci/R&D Officer | 14/04/2010 | - |
Founder | 31/12/2007 | - |
Career history of Jens Kjeldsen-Kragh
Former positions of Jens Kjeldsen-Kragh
Companies | Position | Start | End |
---|---|---|---|
University of Oslo | Corporate Officer/Principal | - | - |
Statistics
International
Norway | 3 |
Operational
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Corporate Officer/Principal | 1 |
Sectoral
Health Technology | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Prophylix AS
![]() Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Health Technology |
- Stock Market
- Insiders
- Jens Kjeldsen-Kragh
- Experience